Science Based Targets initiative (SBTi) Confirms Contribution of Merck KGaA, Darmstadt, Germany, to 1.5°C Climate Target
Merck KGaA, Darmstadt, Germany, a leading science and technology company, aims to significantly reduce its greenhouse gas emissions by 2030. The independent Science Based Targets initiative (SBTi) has now confirmed that the company’s targets correspond to the current status of climate science. Consequently, Merck KGaA, Darmstadt, Germany, is helping to limit global warming to 1.5°C, thus meeting the requirements of the Paris Agreement.
“The Paris Climate goals remain within reach if the world can unite around science and technology. The verification of the company’s 2030 targets by the Science Based Targets initiative, an independent and respected body, underlines our commitment to remain transparent and accountable throughout our entire sustainability journey,” said Belén Garijo, Chair of the Executive Board and CEO of Merck KGaA, Darmstadt, Germany.
The Science Based Targets initiative has confirmed the following targets of Merck KGaA, Darmstadt, Germany:
- Merck KGaA, Darmstadt, Germany, has committed to lowering its absolute direct (Scope 1) and indirect (Scope 2) greenhouse gas emissions by 50% by 2030. The baseline year is 2020.
- Moreover, Merck KGaA, Darmstadt, Germany, has pledged to lower its indirect emissions along the entire value chain (Scope 3) by 52% per euro value added by 2030. The baseline year is also 2020.
The achievement of the target for Scope 1 and Scope 2 is also part of the compensation system of the members of the Executive Board.
The climate targets are part of the sustainability strategy of Merck KGaA, Darmstadt, Germany. With this strategy, the company is pursuing specific goals in the areas of sustainable science and technology and value chains as well as climate change and the environment. By 2040, Merck KGaA, Darmstadt, Germany, intends to achieve climate-neutral operations and lower its resource consumption, among other things. In doing so, the company will also contribute to the achievement of the UN Sustainable Development Goals (SDGs).
All Merck KGaA, Darmstadt, Germany, press releases are distributed by e-mail at the same time they become available on the EMD Group website. In case you are a resident of the USA or Canada, please go to www.emdgroup.com/subscribe to register online, change your selection or discontinue this service.
About Merck KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt, Germany, a leading science and technology company, operates across life science, healthcare and electronics. Around 60,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From advancing gene editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2021, Merck KGaA, Darmstadt, Germany, generated sales of € 19.7 billion in 66 countries.
The company holds the global rights to the name and trademark “Merck” internationally. The only exceptions are the United States and Canada, where the business sectors of Merck KGaA, Darmstadt, Germany, operate as MilliporeSigma in life science, EMD Serono in healthcare and EMD Electronics in electronics. Since its founding in 1668, scientific exploration and responsible entrepreneurship have been key to the company’s technological and scientific advances. To this day, the founding family remains the majority owner of the publicly listed company.
MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, has doubled its high-potent active pharmaceutical ingredients (HPAPI) production capacity with the expansion of ...